SHP Substrate 1 Recombinant Protein: Mechanisms, Applications and Research Tools

Concept 

SHP Substrate 1 recombinant protein is a pivotal research tool in the fields of immune regulation and cell signal transduction studies. It acts as a key interacting partner for SHP-1 and SHP-2 phosphatases, harboring conserved functional motifs including the immunoreceptor tyrosine-based inhibitory motif (ITIM, Y241) and immunoreceptor tyrosine-based switch motif (ITSM, Y263) within its intracellular domain. This protein mediates the negative regulation of immune receptor signaling pathways and is widely used to elucidate phosphatase-mediated signal modulation mechanisms, making it indispensable for basic and translational life science research.

Research Frontiers

Recent years have witnessed remarkable progress in the molecular engineering, preparation and functional exploration of SHP Substrate 1 recombinant protein. Researchers have optimized its molecular design by constructing truncated variants containing the complete intracellular domain (amino acids 183-268) to preserve full binding activity with SHP-1/SHP-2. For specialized research such as palmitoylation modification analysis, constructs incorporating the transmembrane region (amino acids 160-182) have also been developed.

Advancements in expression system selection and optimization have further enhanced the protein’s functional performance, while innovative purification strategies and rigorous functional validation protocols ensure high purity, activity and batch-to-batch consistency. Additionally, cutting-edge structural biology and molecular interaction studies have uncovered the underlying mechanisms of SHP Substrate 1 in regulating phosphatase activity and immune signal inhibition, opening new avenues for drug development and diagnostic tool design.

Research Significance 

The study of SHP Substrate 1 recombinant protein holds profound scientific and translational significance. At the basic research level, it unravels the molecular mechanisms of SHP phosphatase-mediated immune signal regulation, clarifying the spatial and temporal specificity of inhibitory signal transduction in immune synapses and enriching the understanding of cell signal network dynamics.

In translational research, this protein serves as a core tool for the development of immune modulators, anti-cancer and autoimmune disease drugs, as its interaction with SHP-2 is a promising therapeutic target. It also acts as a critical standard and capture reagent for diagnostic assay development, enabling accurate detection of disease-related biomarkers and pharmacodynamic evaluation of targeted therapies. Moreover, its applications in cell therapy and gene engineering accelerate the development of novel cell modification and stem cell differentiation strategies, laying a foundation for innovative clinical treatments.

Mechanisms, Research Methods and Product Applications

Molecular Mechanisms of Action

Phosphorylated SHP Substrate 1 recombinant protein activates SHP-2 phosphatase activity in a dose-dependent manner, elevating the catalytic efficiency (kcat/Km) by 50-100 fold under optimal physiological conditions (pH 7.0, 25°C). This activation is achieved through two core mechanisms: the release of SHP-2’s autoinhibited conformation (N-SH2 domain dissociation from the catalytic site) and the enhancement of substrate binding affinity (Kd reduction from 8 μM to 0.5 μM). Doubly phosphorylated SHP Substrate 1 (Y241+Y263) exerts a synergistic activation effect on SHP-2, which is 3-5 times stronger than the singly phosphorylated form, mediating signal amplification in cellular contexts.

In immune signal inhibition, phosphorylated SHP Substrate 1 recruits SHP-2 to the TCR signaling complex, inducing dephosphorylation of key components such as ZAP70 (Y492) and reducing its activity by over 70%. Its inhibitory effect exhibits a concentration threshold (10 μM local concentration), which is critical for the spatial specificity of immune synapse signal regulation. Additionally, SHP Substrate 1 acts as a signal hub, interacting with over 40 proteins including adaptors (Grb2, Gads), kinases (Lyn, Fyn) and E3 ubiquitin ligases (Cbl) through polyvalent binding, integrating multiple cellular signaling pathways.

Key Research Methods

1. Protein Preparation and Characterization: Truncated or full-length constructs are expressed in optimized systems (E. coli, insect cells, mammalian cells) with affinity tags (GST, His6, FLAG/HA). Purification involves affinity chromatography, protease cleavage, gel filtration and buffer exchange, with quality control including purity (>95%), endotoxin level (<0.1 EU/μg) and monodispersity verification (polydispersity index <0.2) via dynamic light scattering.
2. Modification and Functional Validation: In vitro phosphorylation by Src family kinases (Lyn) and palmitoylation labeling with ³H-palmitic acid are used for post-translational modification analysis. Functional validation includes surface plasmon resonance (SPR) for SHP-2 binding affinity (normal Kd: 0.5-2 μM), phosphatase activity assays and cellular TCR signal inhibition experiments.
3. Structural and Interaction Studies: X-ray crystallography and cryo-electron microscopy resolve the atomic structures of SHP Substrate 1-SHP-2 complexes, while hydrogen-deuterium exchange mass spectrometry (HDX-MS) and molecular dynamics simulations elucidate conformational changes induced by binding. Affinity purification-mass spectrometry (AP-MS) identifies interacting proteins, and single-molecule fluorescence techniques (FRET, TIRF) track real-time SHP-2 recruitment and activation.
4. Translational Research Assays: Structure-based virtual screening and high-throughput phosphatase analysis enable drug screening for SHP-2 modulators. ELISA, phosphorylation-specific flow cytometry and microfluidic detection platforms are developed for diagnostic applications, with CAR-T cell modification and stem cell differentiation assays for cell therapy research.

Applications of SHP Substrate 1 Recombinant Protein in Research

1. Drug Discovery: Serves as a core tool for immune modulator and anti-cancer drug development. Structure-based virtual screening using the SHP-2/SHP Substrate 1 complex crystal structure (PDB 6N6F) identifies lead compounds disrupting the interaction (IC50: 2-10 μM). High-throughput screening systems with this protein can evaluate over 10,000 compounds daily, and AlphaScreen-based assays (Z' factor >0.7) support large-scale drug screening.
2. Diagnostic Development: Acts as a standard and capture reagent for quantitative ELISA (serum soluble SHP Substrate 1 normal range: 2-8 ng/mL), phosphorylation-specific flow cytometry and microfluidic detection platforms, enabling disease activity monitoring (e.g., rheumatoid arthritis, DAS28 score r=0.62) and pharmacodynamic evaluation of targeted therapies.
3. Cell Therapy & Gene Engineering: Fused with CD28 transmembrane domain for CAR-T cell modification, improving cell persistence by 3-fold in mouse models. Coated on plates (2 μg/cm²) to enhance hematopoietic progenitor cell differentiation into CD4+CD25+FoxP3+ Treg cells (40% yield increase), and used as a positive control for CRISPR-Cas9 editing efficiency verification. Magnetic nanoparticle coupling enables targeted immune modulation in tissue-specific disease models (e.g., arthritis).
4. Basic Signal Transduction Research: Facilitates in vitro reconstruction of inhibitory signaling complexes, real-time observation of SHP-2 dynamic regulation via single-molecule techniques, and identification of novel regulatory factors (SH3KBP1, PAG1) through AP-MS. Cross-species functional comparison (human, mouse, rat) identifies conserved sequence modules for targeted drug design.

Related Products from AN BIO PTE. LTD.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.